Cargando…

An Overview of Circulating Cell-Free Nucleic Acids in Diagnosis and Prognosis of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer due to its molecular heterogeneity and poor clinical outcomes. Analysis of circulating cell-free tumor nucleic acids (ctNAs) can improve our understanding of TNBC and provide efficient and non-invasive clinical biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tierno, Domenico, Grassi, Gabriele, Zanconati, Fabrizio, Bortul, Marina, Scaggiante, Bruna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864244/ https://www.ncbi.nlm.nih.gov/pubmed/36675313 http://dx.doi.org/10.3390/ijms24021799

Ejemplares similares

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023)

A Case–Control Study by ddPCR of ALU 260/111 and LINE-1 266/97 Copy Number Ratio in Circulating Cell-Free DNA in Plasma Revealed LINE-1 266/97 as a Potential Biomarker for Early Breast Cancer Detection
por: Bortul, Marina, et al.
Publicado: (2023)

Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer
por: Sobhani, Navid, et al.
Publicado: (2020)

Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
por: Giudici, Fabiola, et al.
Publicado: (2019)

Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis
por: Giudici, Fabiola, et al.
Publicado: (2019)

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
por: Bosutti, Alessandra, et al.
Publicado: (2016)

Circulating Cell-Free Nucleic Acids as Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023)

Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches
por: Jesenko, Tanja, et al.
Publicado: (2023)

Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study
por: Alborelli, Ilaria, et al.
Publicado: (2019)

An Overview of siRNA Delivery Strategies for Urological Cancers
por: Halib, Nadia, et al.
Publicado: (2022)

High eEF1A1 Protein Levels Mark Aggressive Prostate Cancers and the In Vitro Targeting of eEF1A1 Reveals the eEF1A1–actin Complex as a New Potential Target for Therapy
por: Bosutti, Alessandra, et al.
Publicado: (2022)

Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules
por: Tonon, Federica, et al.
Publicado: (2021)

Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer
por: Gahan, Peter Brian
Publicado: (2010)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets
por: Claps, Francesco, et al.
Publicado: (2023)

Triple Negative Breast Cancer – An Overview
por: Aysola, Kartik, et al.
Publicado: (2013)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Comparison between male and female breast cancer survival using propensity score matching analysis
por: Scomersi, Serena, et al.
Publicado: (2021)

Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression
por: Scaggiante, B, et al.
Publicado: (2012)

Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'
por: Shin, Vivian Y, et al.
Publicado: (2016)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Association between benign thyroid disease and breast cancer: a single center experience
por: Dobrinja, Chiara, et al.
Publicado: (2019)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation
por: Ramezanzadeh, Mahboubeh, et al.
Publicado: (2017)

Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application
por: Szilágyi, Melinda, et al.
Publicado: (2020)

Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
por: Rahat, Beenish, et al.
Publicado: (2020)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment
por: Campaner, Elena, et al.
Publicado: (2020)

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer
por: Dameri, Martina, et al.
Publicado: (2021)

Role of Circulating Tumor Cell (CTC) Monitoring in Evaluating Prognosis of Triple-Negative Breast Cancer Patients in China
por: Zhang, Yanwu, et al.
Publicado: (2017)

Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer
por: Zeng, Zhihao, et al.
Publicado: (2017)

The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2022)

Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2023)

Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer
por: Gourdin, Theodore, et al.
Publicado: (2018)

Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders
por: Turchinovich, Andrey, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3jhf911jufva54ak2t5md6vjrl